Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risks of Bacterial and Fungal Superinfection in Patients With COVID-19 Stratified by New and Pre-existing Immunosuppression: a Retrospective, Observational, Multisite, Multinational Cohort Study

NCT05256316 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT05256316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05256316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19 Stratified by New and Pre-existing Immunosuppression: a Retrospective, Observational, Multisite, Multinational Cohort Study
Lead sponsor
The University of Queensland
Phase
Observational
Overall status
Completed
Start date
February 14, 2022
Completion date
December 4, 2022
Enrollment
790 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19